Catalyst Wire Dossier Catalyst Wire Dossier

Obgemsa

vibegron · Pierre Fabre Medicament
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Obgemsa, covering 2025-07-08 to 2025-07-08. Get the full timeline:

Most recent: EMA Authorised: Obgemsa (vibegron) — Pierre Fabre Medicament

See pricing